Display Settings:

Format

Send to:

Choose Destination
    Diabetes Care. 2010 Aug;33(8):1699-705. Epub 2010 Apr 27.

    Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes.

    Source

    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. j.beulens@umcutrecht.nl

    Abstract

    OBJECTIVE:

    To investigate whether dietary phylloquinone and menaquinones intakes are related to risk of type 2 diabetes.

    RESEARCH DESIGN AND METHODS:

    We used data from a prospective cohort study in 38,094 Dutch men and women, aged 20-70 years. Dietary phylloquinone and menaquinones intakes were assessed using a validated food frequency questionnaire. Diabetes case patients were ascertained mainly via self-report and verified against medical records.

    RESULTS:

    During 10.3 years of follow-up, 918 incident cases of diabetes were documented. In a multivariate model adjusting for diabetes risk factors and dietary factors, phylloquinone intake tended to be associated (P = 0.08) with a reduced risk of type 2 diabetes with a hazard ratio (HR) of 0.81 (95% CI 0.66-0.99) for the highest versus the lowest quartile. For menaquinones intake, a linear, inverse association (P = 0.038) with risk of type 2 diabetes was observed with an HR of 0.93 (0.87-1.00) for each 10-microg increment in the multivariate model.

    CONCLUSIONS:

    This study shows that both phylloquinone and menaquinones intakes may be associated with a reduced risk of type 2 diabetes.

    PMID:
    20424220
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2909045
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk